BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30105118)

  • 1. Paroxysmal Movement Disorder and Epilepsy Caused by a De Novo Truncating Mutation in
    Efthymiou S; Salpietro V; Bettencourt C; Houlden H
    J Pediatr Genet; 2018 Sep; 7(3):114-116. PubMed ID: 30105118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.
    Arboleda VA; Lee H; Dorrani N; Zadeh N; Willis M; Macmurdo CF; Manning MA; Kwan A; Hudgins L; Barthelemy F; Miceli MC; Quintero-Rivera F; Kantarci S; Strom SP; Deignan JL; ; Grody WW; Vilain E; Nelson SF
    Am J Hum Genet; 2015 Mar; 96(3):498-506. PubMed ID: 25728775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epilepsy in KAT6A syndrome: Description of two individuals and revision of the literature.
    Troisi S; Maitz S; Severino M; Spano A; Cappuccio G; Brunetti-Pierri N; Torella A; Nigro V; Tudp ; Bilo L; Coppola A
    Eur J Med Genet; 2022 Jan; 65(1):104380. PubMed ID: 34748993
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Singh M; Spendlove S; Wei A; Bondhus L; Nava A; de L Vitorino FN; Amano S; Lee J; Echeverria G; Gomez D; Garcia BA; Arboleda VA
    bioRxiv; 2023 Aug; ():. PubMed ID: 37577627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A KAT6A variant in a family with autosomal dominantly inherited microcephaly and developmental delay.
    Trinh J; Hüning I; Yüksel Z; Baalmann N; Imhoff S; Klein C; Rolfs A; Gillessen-Kaesbach G; Lohmann K
    J Hum Genet; 2018 Sep; 63(9):997-1001. PubMed ID: 29899504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the Chromatin Regulator Gene BRPF1 Cause Syndromic Intellectual Disability and Deficient Histone Acetylation.
    Yan K; Rousseau J; Littlejohn RO; Kiss C; Lehman A; Rosenfeld JA; Stumpel CTR; Stegmann APA; Robak L; Scaglia F; Nguyen TTM; Fu H; Ajeawung NF; Camurri MV; Li L; Gardham A; Panis B; Almannai M; Sacoto MJG; Baskin B; Ruivenkamp C; Xia F; Bi W; ; ; Cho MT; Potjer TP; Santen GWE; Parker MJ; Canham N; McKinnon M; Potocki L; MacKenzie JJ; Roeder ER; Campeau PM; Yang XJ
    Am J Hum Genet; 2017 Jan; 100(1):91-104. PubMed ID: 27939640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAT6A mutations in Arboleda-Tham syndrome drive epigenetic regulation of posterior HOXC cluster.
    Singh M; Spendlove SJ; Wei A; Bondhus LM; Nava AA; de L Vitorino FN; Amano S; Lee J; Echeverria G; Gomez D; Garcia BA; Arboleda VA
    Hum Genet; 2023 Dec; 142(12):1705-1720. PubMed ID: 37861717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.
    Tham E; Lindstrand A; Santani A; Malmgren H; Nesbitt A; Dubbs HA; Zackai EH; Parker MJ; Millan F; Rosenbaum K; Wilson GN; Nordgren A
    Am J Hum Genet; 2015 Mar; 96(3):507-13. PubMed ID: 25728777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three brothers with a nonsense mutation in
    Satoh C; Maekawa R; Kinoshita A; Mishima H; Doi M; Miyazaki M; Fukuda M; Takahashi H; Kondoh T; Yoshiura KI
    Hum Genome Var; 2017; 4():17045. PubMed ID: 31754438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantothenate and L-Carnitine Supplementation Improves Pathological Alterations in Cellular Models of KAT6A Syndrome.
    Munuera-Cabeza M; Álvarez-Córdoba M; Suárez-Rivero JM; Povea-Cabello S; Villalón-García I; Talaverón-Rey M; Suárez-Carrillo A; Reche-López D; Cilleros-Holgado P; Piñero-Pérez R; Sánchez-Alcázar JA
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speech and language development and genotype-phenotype correlation in 49 individuals with KAT6A syndrome.
    St John M; Amor DJ; Morgan AT
    Am J Med Genet A; 2022 Dec; 188(12):3389-3400. PubMed ID: 35892268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation.
    Asadollahi R; Zweier M; Gogoll L; Schiffmann R; Sticht H; Steindl K; Rauch A
    Eur J Med Genet; 2017 Sep; 60(9):451-464. PubMed ID: 28645799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Have We Learned from Patients Who Have Arboleda-Tham Syndrome Due to a De Novo
    Bukvic N; Chetta M; Bagnulo R; Leotta V; Pantaleo A; Palumbo O; Palumbo P; Oro M; Rivieccio M; Laforgia N; De Rinaldis M; Rosati A; Kerkhof J; Sadikovic B; Resta N
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel De Novo Frameshift Mutation in
    Alkhateeb A; Alazaizeh W
    J Pediatr Genet; 2019 Mar; 8(1):10-14. PubMed ID: 30775047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the genetic basis of comorbid epilepsy phenotypes in neurodevelopmental disorders.
    Chow J; Jensen M; Amini H; Hormozdiari F; Penn O; Shifman S; Girirajan S; Hormozdiari F
    Genome Med; 2019 Oct; 11(1):65. PubMed ID: 31653223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex Neurological Phenotype Associated with a De Novo
    Piccolo G; Amadori E; Vari MS; Marchese F; Riva A; Ghirotto V; Iacomino M; Salpietro V; Zara F; Striano P
    J Pediatr Genet; 2021 Sep; 10(3):236-238. PubMed ID: 34504728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food allergy in a child with de novo
    Elenius V; Lähdesmäki T; Hietala M; Jartti T
    Clin Transl Allergy; 2017; 7():19. PubMed ID: 28649320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A de novo missense mutation in ZMYND11 is associated with global developmental delay, seizures, and hypotonia.
    Moskowitz AM; Belnap N; Siniard AL; Szelinger S; Claasen AM; Richholt RF; De Both M; Corneveaux JJ; Balak C; Piras IS; Russell M; Courtright AL; Rangasamy S; Ramsey K; Craig DW; Narayanan V; Huentelman MJ; Schrauwen I
    Cold Spring Harb Mol Case Stud; 2016 Sep; 2(5):a000851. PubMed ID: 27626064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncating de novo mutations in the Krüppel-type zinc-finger gene ZNF148 in patients with corpus callosum defects, developmental delay, short stature, and dysmorphisms.
    Stevens SJ; van Essen AJ; van Ravenswaaij CM; Elias AF; Haven JA; Lelieveld SH; Pfundt R; Nillesen WM; Yntema HG; van Roozendaal K; Stegmann AP; Gilissen C; Brunner HG
    Genome Med; 2016 Dec; 8(1):131. PubMed ID: 27964749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.